To ask Her Majesty's Government when they will publish their Digital Charter to address online bullying.
- Contact information
- Parliamentary career
- Experience
- Focus areas
- Voting record
- Spoken contributions
- Written questions
- Register of Interests
- APPG officer roles
- Staff
- Official portrait
Written questions
Review the written questions submitted by Lord Mancroft.
To perform a more comprehensive search of written questions, visit the Parliamentary written questions and answers website.
To ask Her Majesty's Government how many European Firearms Passes were issued to firearms certificate holders in 2016.
To ask Her Majesty's Government what assessment they have made of the benefits of continued participation in, and recognition of, the European Firearms Pass arrangements after the UK has left the EU.
To ask Her Majesty's Government what was the cost of treatment with anti-viral drugs for each hepatitis C patient treated by NHS England in 2016–17.
To ask Her Majesty's Government how many hepatitis C patients were treated using the new anti-viral drugs by NHS England in the year 2016–17; and what proportion remain free of the virus post-treatment.
To ask Her Majesty's Government how many patients diagnosed with hepatitis C remain to be treated with new anti-viral drugs; and when NHS England expect them all to have received such treatment.
To ask Her Majesty's Government how many hepatitis C patients NHS England intend to treat using the new anti-viral drugs in 2017–18.
To ask Her Majesty’s Government what assessment they have made of whether the procurement exercises for hepatitis C medicines have resulted in lower costs to the NHS of hepatitis C medicines than those costs which informed the guidance set out in technolo...
To ask Her Majesty’s Government whether savings realised through the procurement exercises for hepatitis C medicines were taken into account by the National Institute for Health and Care Excellence in its cost modelling in technology appraisals 363, 364 a...
To ask Her Majesty’s Government whether procurement exercises have taken place to reduce the prices paid by the NHS for new hepatitis C medicines.
To ask Her Majesty’s Government on what basis, if any, the NHS Mandate requires that investment in NICE-recommended treatments for hepatitis C be limited to avoid disinvestment in other health services.
To ask Her Majesty’s Government what is the breakdown of the patient treatment capacity for each Operational Delivery Network for hepatitis C, broken down by hub and spoke.
To ask Her Majesty’s Government what is the breakdown of run rates assigned to each Operational Delivery Network for hepatitis C, broken down by hub and spoke.
To ask Her Majesty’s Government which current policy document or guidance, if any, specified a five-year rollout for the prioritised treatment of hepatitis C patients.
To ask Her Majesty’s Government when NHS England expects to publish its operational framework for hepatitis C.
To ask Her Majesty’s Government what impact assessment they made of the introduction of CQUIN scheme BI1 Improving HCV Treatment Pathways through ODNs, and whether they will publish a copy of that assessment.
To ask Her Majesty’s Government whether NHS England's decision to treat 10,000 hepatitis C patients represents a cap on the number of patients the NHS can treat in 2016–17.
To ask Her Majesty’s Government whether patients who meet the eligibility criteria for NICE-approved medicines for hepatitis C will have access to treatment in line with their rights under the NHS Constitution in 2016–17, even if more than 10,000 patients...
To ask Her Majesty’s Government on which specific NICE guidance NHS England based its decision to restrict access to new treatments for hepatitis C to 10,000 patients in 2016–17.
To ask Her Majesty’s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.